SCM
GOSS icon

Silverarc Capital Management’s Gossamer Bio GOSS Stock Holding History

Silverarc Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,135,722
Closed -$6.62M – 78
2025
Q4 		$6.62M Sell
2,135,722
-2,643,360
-55% -$7.54M 0.92% 30
2025
Q3 		$12.6M Sell
4,779,082
-367,700
-7% -$810K 1.69% 18
2025
Q2 		$6.33M Sell
5,146,782
-1,173,902
-19% -$1.28M 1.17% 24
2025
Q1 		$6.95M Buy
6,320,684
+148,837
+2% +$172K 1.42% 22
2024
Q4 		$5.58M Buy
6,171,847
+526,495
+9% +$451K 1.22% 28
2024
Q3 		$5.57M Buy
5,645,352
+145,352
+3% +$140K 1.25% 27
2024
Q2 		$4.95M Sell
5,500,000
-630,268
-10% -$472K 1.17% 29
2024
Q1 		$7.23M Hold
6,130,268
– – 2.01% 17
2023
Q4 		$5.59M Hold
6,130,268
– – 1.67% 24
2023
Q3 		$5.11M Buy
+6,130,268
New +$7.06M 1.55% 28
2023
Q1 		– Sell
-100,000
Closed -$217K – 89
2022
Q4 		$217K Buy
+100,000
New +$823K 0.06% 85

Other funds holding GOSS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Silverarc Capital Management's GOSS Position: Q1 2026 in Review

Silverarc Capital Management sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 2,135,722 shares — an estimated $6.62M sold.

Silverarc Capital Management first reported a position in GOSS in Q4 2022 and held it in 11 quarters. The position peaked at $12.6M in Q3 2025. 185 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Silverarc Capital Management reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
  • Silverarc Capital Management sold 2,135,722 Gossamer Bio shares in Q1 2026, an estimated $6.62M.
  • Silverarc Capital Management first reported a position in Gossamer Bio in Q4 2022 and held it in 11 quarters.
  • Silverarc Capital Management's Gossamer Bio position peaked at $12.6M in Q3 2025.
  • 185 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Silverarc Capital Management's 13F filing for Q1 2026, filed 14 May 2026.